156 related articles for article (PubMed ID: 15322201)
1. A novel recombinant multisubunit vaccine against Chlamydia.
Eko FO; He Q; Brown T; McMillan L; Ifere GO; Ananaba GA; Lyn D; Lubitz W; Kellar KL; Black CM; Igietseme JU
J Immunol; 2004 Sep; 173(5):3375-82. PubMed ID: 15322201
[TBL] [Abstract][Full Text] [Related]
2. Recombinant Vibrio cholerae ghosts as a delivery vehicle for vaccinating against Chlamydia trachomatis.
Eko FO; Lubitz W; McMillan L; Ramey K; Moore TT; Ananaba GA; Lyn D; Black CM; Igietseme JU
Vaccine; 2003 Apr; 21(15):1694-703. PubMed ID: 12639492
[TBL] [Abstract][Full Text] [Related]
3. Live-attenuated influenza viruses as delivery vectors for Chlamydia vaccines.
He Q; Martinez-Sobrido L; Eko FO; Palese P; Garcia-Sastre A; Lyn D; Okenu D; Bandea C; Ananaba GA; Black CM; Igietseme JU
Immunology; 2007 Sep; 122(1):28-37. PubMed ID: 17451464
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of the protective efficacy of two formulations of a recombinant Chlamydia abortus subunit candidate vaccine in a mouse model.
Pan Q; Pais R; Ohandjo A; He C; He Q; Omosun Y; Igietseme JU; Eko FO
Vaccine; 2015 Apr; 33(15):1865-72. PubMed ID: 25698486
[TBL] [Abstract][Full Text] [Related]
5. A Vibrio cholerae ghost-based subunit vaccine induces cross-protective chlamydial immunity that is enhanced by CTA2B, the nontoxic derivative of cholera toxin.
Ekong EE; Okenu DN; Mania-Pramanik J; He Q; Igietseme JU; Ananaba GA; Lyn D; Black C; Eko FO
FEMS Immunol Med Microbiol; 2009 Mar; 55(2):280-91. PubMed ID: 19040663
[TBL] [Abstract][Full Text] [Related]
6. Chlamydia vaccines: strategies and status.
Igietseme JU; Black CM; Caldwell HD
BioDrugs; 2002; 16(1):19-35. PubMed ID: 11908999
[TBL] [Abstract][Full Text] [Related]
7. Route of Vaccine Administration Influences the Impact of Fms-Like Tyrosine Kinase 3 Ligand (Flt3L) on Chlamydial-Specific Protective Immune Responses.
Pais R; Omosun Y; Igietseme JU; Fujihashi K; Eko FO
Front Immunol; 2019; 10():1577. PubMed ID: 31333682
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a broadly protective Chlamydia-cholera combination vaccine candidate.
Eko FO; Okenu DN; Singh UP; He Q; Black C; Igietseme JU
Vaccine; 2011 May; 29(21):3802-10. PubMed ID: 21421002
[TBL] [Abstract][Full Text] [Related]
9. A recombinant multivalent combination vaccine protects against Chlamydia and genital herpes.
Macmillan L; Ifere GO; He Q; Igietseme JU; Kellar KL; Okenu DM; Eko FO
FEMS Immunol Med Microbiol; 2007 Feb; 49(1):46-55. PubMed ID: 17094789
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and protection against genital Chlamydia infection and its complications by a multisubunit candidate vaccine.
Ifere GO; He Q; Igietseme JU; Ananaba GA; Lyn D; Lubitz W; Kellar KL; Black CM; Eko FO
J Microbiol Immunol Infect; 2007 Jun; 40(3):188-200. PubMed ID: 17639158
[TBL] [Abstract][Full Text] [Related]
11. Induction of immune memory by a multisubunit chlamydial vaccine.
Eko FO; Ekong E; He Q; Black CM; Igietseme JU
Vaccine; 2011 Feb; 29(7):1472-80. PubMed ID: 21184858
[TBL] [Abstract][Full Text] [Related]
12. A multi-subunit Chlamydia vaccine inducing neutralizing antibodies and strong IFN-γ⁺ CMI responses protects against a genital infection in minipigs.
Bøje S; Olsen AW; Erneholm K; Agerholm JS; Jungersen G; Andersen P; Follmann F
Immunol Cell Biol; 2016 Feb; 94(2):185-95. PubMed ID: 26268662
[TBL] [Abstract][Full Text] [Related]
13. Contemporary approaches to designing and evaluating vaccines against Chlamydia.
Igietseme JU; Eko FO; Black CM
Expert Rev Vaccines; 2003 Feb; 2(1):129-46. PubMed ID: 12901604
[TBL] [Abstract][Full Text] [Related]
14. Protective immunity against Chlamydia trachomatis genital infection induced by a vaccine based on the major outer membrane multi-epitope human papillomavirus major capsid protein L1.
Xu W; Liu J; Gong W; Chen J; Zhu S; Zhang L
Vaccine; 2011 Mar; 29(15):2672-8. PubMed ID: 21324344
[TBL] [Abstract][Full Text] [Related]
15. Recombinant expression of Chlamydia trachomatis major outer membrane protein in E. Coli outer membrane as a substrate for vaccine research.
Wen Z; Boddicker MA; Kaufhold RM; Khandelwal P; Durr E; Qiu P; Lucas BJ; Nahas DD; Cook JC; Touch S; Skinner JM; Espeseth AS; Przysiecki CT; Zhang L
BMC Microbiol; 2016 Jul; 16(1):165. PubMed ID: 27464881
[TBL] [Abstract][Full Text] [Related]
16. Cellular Basis for the Enhanced Efficacy of the Fms-Like Tyrosine Kinase 3 Ligand (FL) Adjuvanted VCG-Based
Richardson S; Medhavi F; Tanner T; Lundy S; Omosun Y; Igietseme JU; Carroll D; Eko FO
Front Immunol; 2021; 12():698737. PubMed ID: 34249004
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of an ompA-based phage-mediated DNA vaccine against Chlamydia abortus in piglets.
Ou C; Tian D; Ling Y; Pan Q; He Q; Eko FO; He C
Int Immunopharmacol; 2013 Aug; 16(4):505-10. PubMed ID: 23669337
[TBL] [Abstract][Full Text] [Related]
18. Comparison of immune responses and protective efficacy of intranasal prime-boost immunization regimens using adenovirus-based and CpG/HH2 adjuvanted-subunit vaccines against genital Chlamydia muridarum infection.
Brown TH; David J; Acosta-Ramirez E; Moore JM; Lee S; Zhong G; Hancock RE; Xing Z; Halperin SA; Wang J
Vaccine; 2012 Jan; 30(2):350-60. PubMed ID: 22075089
[TBL] [Abstract][Full Text] [Related]
19. Immunization of a wild koala population with a recombinant Chlamydia pecorum Major Outer Membrane Protein (MOMP) or Polymorphic Membrane Protein (PMP) based vaccine: New insights into immune response, protection and clearance.
Desclozeaux M; Robbins A; Jelocnik M; Khan SA; Hanger J; Gerdts V; Potter A; Polkinghorne A; Timms P
PLoS One; 2017; 12(6):e0178786. PubMed ID: 28575080
[TBL] [Abstract][Full Text] [Related]
20. GM-CSF transgene-based adjuvant allows the establishment of protective mucosal immunity following vaccination with inactivated Chlamydia trachomatis.
Lu H; Xing Z; Brunham RC
J Immunol; 2002 Dec; 169(11):6324-31. PubMed ID: 12444139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]